Tempest Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Seeks to create distinct and transformative treatments where there is a significant unmet medical need.
$3.86 -0.05 (-1.28%)
As of 05/26/2022 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.